UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2020	$ 36	$ 115	$ (8,281)	$ 110,951	$ 102,822
Equity Balance, shares at Dec. 31, 2020	3,643
Common stock issued upon exercise of employee stock options	$ 0	281	0	0	281
Common stock issued upon exercise of employee stock options, shares	6
Stock option compensation expense	$ 0	123	0	0	123
Foreign currency translation adjustment	0	0	(787)	0	(787)
Common stock dividends	0	0	0	(3,116)	(3,116)
Net income	0	0	0	10,656	10,656
Equity Balance, value at Sep. 30, 2021	$ 36	520	(9,068)	118,492	109,980
Equity Balance, shares at Sep. 30, 2021	3,649
Equity Balance, value at Jun. 30, 2021	$ 36	289	(8,286)	115,326	107,365
Equity Balance, shares at Jun. 30, 2021	3,646
Common stock issued upon exercise of employee stock options	$ 0	189	0	0	189
Common stock issued upon exercise of employee stock options, shares	3
Stock option compensation expense	$ 0	41	0	0	41
Foreign currency translation adjustment	0	0	(782)	0	(782)
Common stock dividends	0	0	0	(1,040)	(1,040)
Net income	0	0	0	4,206	4,206
Equity Balance, value at Sep. 30, 2021	$ 36	520	(9,068)	118,492	109,980
Equity Balance, shares at Sep. 30, 2021	3,649
Equity Balance, value at Dec. 31, 2021	$ 37	841	(9,054)	115,314	107,138
Equity Balance, shares at Dec. 31, 2021	3,655
Common stock issued upon exercise of employee stock options	$ 0	43	0	0	43
Common stock issued upon exercise of employee stock options, shares	1
Stock option compensation expense	$ 0	121	0	0	121
Common stock purchased and retired	$ (1)	(947)	0	(1,548)	(2,495)
Common stock purchased and retired, shares	(30)
Foreign currency translation adjustment	$ 0	0	(5,377)	0	(5,377)
Common stock dividends	0	0	0	(3,162)	(3,162)
Net income	0	0	0	11,918	11,918
Equity Balance, value at Sep. 30, 2022	$ 36	58	(14,431)	122,521	108,185
Equity Balance, shares at Sep. 30, 2022	3,625
Equity Balance, value at Jun. 30, 2022	$ 36	0	(11,858)	119,293	107,471
Equity Balance, shares at Jun. 30, 2022	3,625
Common stock issued upon exercise of employee stock options	$ 0	20	0	0	20
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	38	0	0	38
Foreign currency translation adjustment	0	0	(2,572)	0	(2,572)
Common stock dividends	0	0	0	(1,051)	(1,051)
Net income	0	0	0	4,280	4,280
Equity Balance, value at Sep. 30, 2022	$ 36	$ 58	$ (14,431)	$ 122,521	$ 108,185
Equity Balance, shares at Sep. 30, 2022	3,625